Treadmill exercise tests in persons with Parkinson’s disease: responses and disease severity

Mon S. Bryant, George R. Jackson, Jyhgong Gabriel Hou, Elizabeth J. Protas

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background and aims: There is a paucity of information on cardiovascular responses with regard to the disease stage of Parkinson’s disease (PD) when using an exercise test. Our purpose was to examine whether cardiovascular responses to the treadmill exercise test differed among persons with PD who have different disease severity. Methods: Forty-five subjects with PD were studied (34 men and 11 women). The subjects underwent a treadmill exercise test using a modified Bruce protocol. Resting heart rate (HR), resting blood pressure (BP), maximal HR, maximal BP, exercise duration, maximum percentage HR and METs achieved after the treadmill exercise test were studied. Results: Seventeen subjects were in Hoehn and Yahr Staging Scale (HY) 2, 16 were in HY 2.5, and 12 were in HY 3. HR increased significantly in all three stages. Systolic BP increased significantly in the HY 2 and 2.5, but not the HY 3. Diastolic BP did not change in any stage. Resting HR was lower in the HY 2 compared to the HY 3 and resting systolic BP was higher in HY 2 compared to the HY 2.5. The three HY stages were not different in exercise duration, HR and BP responses, maximum percentage HR achieved, and METs achieved. Fatigue was a primary reason to discontinue the test. There were no fall incidents in any of the tests. Conclusions: Cardiovascular responses to the treadmill exercise test did not vary with disease severity. Treadmill exercise tests were safe to perform in persons with PD.

Original languageEnglish (US)
Pages (from-to)1-6
Number of pages6
JournalAging clinical and experimental research
DOIs
StateAccepted/In press - Nov 21 2015

Fingerprint

Exercise Test
Parkinson Disease
Blood Pressure
Heart Rate
Exercise
Fatigue

Keywords

  • Cardiovascular response
  • Modified Bruce protocol
  • Parkinson’s disease
  • Treadmill exercise test

ASJC Scopus subject areas

  • Aging
  • Geriatrics and Gerontology

Cite this

Treadmill exercise tests in persons with Parkinson’s disease : responses and disease severity. / Bryant, Mon S.; Jackson, George R.; Hou, Jyhgong Gabriel; Protas, Elizabeth J.

In: Aging clinical and experimental research, 21.11.2015, p. 1-6.

Research output: Contribution to journalArticle

Bryant, Mon S. ; Jackson, George R. ; Hou, Jyhgong Gabriel ; Protas, Elizabeth J. / Treadmill exercise tests in persons with Parkinson’s disease : responses and disease severity. In: Aging clinical and experimental research. 2015 ; pp. 1-6.
@article{8e2e1bd7b673429aa36f3f5bbfa8afde,
title = "Treadmill exercise tests in persons with Parkinson’s disease: responses and disease severity",
abstract = "Background and aims: There is a paucity of information on cardiovascular responses with regard to the disease stage of Parkinson’s disease (PD) when using an exercise test. Our purpose was to examine whether cardiovascular responses to the treadmill exercise test differed among persons with PD who have different disease severity. Methods: Forty-five subjects with PD were studied (34 men and 11 women). The subjects underwent a treadmill exercise test using a modified Bruce protocol. Resting heart rate (HR), resting blood pressure (BP), maximal HR, maximal BP, exercise duration, maximum percentage HR and METs achieved after the treadmill exercise test were studied. Results: Seventeen subjects were in Hoehn and Yahr Staging Scale (HY) 2, 16 were in HY 2.5, and 12 were in HY 3. HR increased significantly in all three stages. Systolic BP increased significantly in the HY 2 and 2.5, but not the HY 3. Diastolic BP did not change in any stage. Resting HR was lower in the HY 2 compared to the HY 3 and resting systolic BP was higher in HY 2 compared to the HY 2.5. The three HY stages were not different in exercise duration, HR and BP responses, maximum percentage HR achieved, and METs achieved. Fatigue was a primary reason to discontinue the test. There were no fall incidents in any of the tests. Conclusions: Cardiovascular responses to the treadmill exercise test did not vary with disease severity. Treadmill exercise tests were safe to perform in persons with PD.",
keywords = "Cardiovascular response, Modified Bruce protocol, Parkinson’s disease, Treadmill exercise test",
author = "Bryant, {Mon S.} and Jackson, {George R.} and Hou, {Jyhgong Gabriel} and Protas, {Elizabeth J.}",
year = "2015",
month = "11",
day = "21",
doi = "10.1007/s40520-015-0498-x",
language = "English (US)",
pages = "1--6",
journal = "Aging",
issn = "1594-0667",
publisher = "Springer Verlag",

}

TY - JOUR

T1 - Treadmill exercise tests in persons with Parkinson’s disease

T2 - responses and disease severity

AU - Bryant, Mon S.

AU - Jackson, George R.

AU - Hou, Jyhgong Gabriel

AU - Protas, Elizabeth J.

PY - 2015/11/21

Y1 - 2015/11/21

N2 - Background and aims: There is a paucity of information on cardiovascular responses with regard to the disease stage of Parkinson’s disease (PD) when using an exercise test. Our purpose was to examine whether cardiovascular responses to the treadmill exercise test differed among persons with PD who have different disease severity. Methods: Forty-five subjects with PD were studied (34 men and 11 women). The subjects underwent a treadmill exercise test using a modified Bruce protocol. Resting heart rate (HR), resting blood pressure (BP), maximal HR, maximal BP, exercise duration, maximum percentage HR and METs achieved after the treadmill exercise test were studied. Results: Seventeen subjects were in Hoehn and Yahr Staging Scale (HY) 2, 16 were in HY 2.5, and 12 were in HY 3. HR increased significantly in all three stages. Systolic BP increased significantly in the HY 2 and 2.5, but not the HY 3. Diastolic BP did not change in any stage. Resting HR was lower in the HY 2 compared to the HY 3 and resting systolic BP was higher in HY 2 compared to the HY 2.5. The three HY stages were not different in exercise duration, HR and BP responses, maximum percentage HR achieved, and METs achieved. Fatigue was a primary reason to discontinue the test. There were no fall incidents in any of the tests. Conclusions: Cardiovascular responses to the treadmill exercise test did not vary with disease severity. Treadmill exercise tests were safe to perform in persons with PD.

AB - Background and aims: There is a paucity of information on cardiovascular responses with regard to the disease stage of Parkinson’s disease (PD) when using an exercise test. Our purpose was to examine whether cardiovascular responses to the treadmill exercise test differed among persons with PD who have different disease severity. Methods: Forty-five subjects with PD were studied (34 men and 11 women). The subjects underwent a treadmill exercise test using a modified Bruce protocol. Resting heart rate (HR), resting blood pressure (BP), maximal HR, maximal BP, exercise duration, maximum percentage HR and METs achieved after the treadmill exercise test were studied. Results: Seventeen subjects were in Hoehn and Yahr Staging Scale (HY) 2, 16 were in HY 2.5, and 12 were in HY 3. HR increased significantly in all three stages. Systolic BP increased significantly in the HY 2 and 2.5, but not the HY 3. Diastolic BP did not change in any stage. Resting HR was lower in the HY 2 compared to the HY 3 and resting systolic BP was higher in HY 2 compared to the HY 2.5. The three HY stages were not different in exercise duration, HR and BP responses, maximum percentage HR achieved, and METs achieved. Fatigue was a primary reason to discontinue the test. There were no fall incidents in any of the tests. Conclusions: Cardiovascular responses to the treadmill exercise test did not vary with disease severity. Treadmill exercise tests were safe to perform in persons with PD.

KW - Cardiovascular response

KW - Modified Bruce protocol

KW - Parkinson’s disease

KW - Treadmill exercise test

UR - http://www.scopus.com/inward/record.url?scp=84947788051&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84947788051&partnerID=8YFLogxK

U2 - 10.1007/s40520-015-0498-x

DO - 10.1007/s40520-015-0498-x

M3 - Article

C2 - 26590841

AN - SCOPUS:84947788051

SP - 1

EP - 6

JO - Aging

JF - Aging

SN - 1594-0667

ER -